TY - JOUR
T1 - Falls and Physical Inactivity in Patients with Gastrointestinal Cancer and Hand-Foot Syndrome
AU - Komatsu, Hiroko
AU - Yagasaki, Kaori
AU - Hamamoto, Yasuo
AU - Takebayashi, Toru
N1 - Funding Information:
This work was supported by the Japan Society for the Promotion of Science KAKENHI (A) Grant Number 16H02696.
Publisher Copyright:
© 2018 Medknow. All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Objective: This study aims to ascertain the incidence and association of falls and physical inactivity in patients with gastrointestinal cancer and hand-foot syndrome (HFS) after receiving chemotherapy or targeted therapy. Methods: The present cross-sectional study was conducted on 50 outpatients with HFS of Grade 1 or above, according to the National Cancer Institute Common Terminology Criteria for Adverse Events, following the receipt of chemotherapy or targeted therapy for gastrointestinal cancer in Japan between November 2016 and February 2017. For measurement, Dermatology Life Quality Index (DLQI) and the International Physical Activity Questionnaire were used. Data were analyzed by logistic regression analysis. Results: Of the participants, 18% experienced falls and 60% reported physical inactivity. Multivariate logistic regression revealed that the DLQI treatment domain score was the only factor associated with falls (odds ratio [OR] =8.01, 95% confidence interval [CI] =1.27-50.63, P = 0.027). Physical inactivity was associated with DLQI symptom and feeling domain scores (OR = 5.54, 95% CI = 1.26-24.33, P = 0.023) and the with-oxaliplatin or paclitaxel regimen (OR = 3.71, 95% CI = 1.06-13.03, P = 0.041). Conclusions: The results of the present study suggest patients should be informed that HFS is a risk factor for physical inactivity and falls.
AB - Objective: This study aims to ascertain the incidence and association of falls and physical inactivity in patients with gastrointestinal cancer and hand-foot syndrome (HFS) after receiving chemotherapy or targeted therapy. Methods: The present cross-sectional study was conducted on 50 outpatients with HFS of Grade 1 or above, according to the National Cancer Institute Common Terminology Criteria for Adverse Events, following the receipt of chemotherapy or targeted therapy for gastrointestinal cancer in Japan between November 2016 and February 2017. For measurement, Dermatology Life Quality Index (DLQI) and the International Physical Activity Questionnaire were used. Data were analyzed by logistic regression analysis. Results: Of the participants, 18% experienced falls and 60% reported physical inactivity. Multivariate logistic regression revealed that the DLQI treatment domain score was the only factor associated with falls (odds ratio [OR] =8.01, 95% confidence interval [CI] =1.27-50.63, P = 0.027). Physical inactivity was associated with DLQI symptom and feeling domain scores (OR = 5.54, 95% CI = 1.26-24.33, P = 0.023) and the with-oxaliplatin or paclitaxel regimen (OR = 3.71, 95% CI = 1.06-13.03, P = 0.041). Conclusions: The results of the present study suggest patients should be informed that HFS is a risk factor for physical inactivity and falls.
KW - Falls
KW - gastrointestinal cancer
KW - hand-foot skin reaction
KW - hand-foot syndrome
KW - physical activity
UR - http://www.scopus.com/inward/record.url?scp=85056728443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056728443&partnerID=8YFLogxK
U2 - 10.4103/apjon.apjon_8_18
DO - 10.4103/apjon.apjon_8_18
M3 - Article
AN - SCOPUS:85056728443
SN - 2347-5625
VL - 5
SP - 307
EP - 313
JO - Asia-Pacific Journal of Oncology Nursing
JF - Asia-Pacific Journal of Oncology Nursing
IS - 3
ER -